Concepedia

Surina Sikka

SS

Statistics

Publications

5

Citations

147

H-Index

5

Active since

2012

Affiliations

ImmunoGen (United States)(Current)

Surina Sikka is an author at ImmunoGen (United States) specializing in cancer pharmacology, antibody-drug conjugates, and antibody conjugates.

Publications per year

2012–2020

5

Publications

5

A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody–Drug Conjugates (ADCs)

Michael L. Miller, Manami Shizuka, Alan Wilhelm et al. · Molecular Cancer Therapeutics · 2018 · 55 citations · Full text

, , +14

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models

Stuart W. Hicks, Katharine C. Lai, L. Cristina Gavrilescu et al. · Neoplasia · 2017 · 36 citations · Full text

, , +17

Assay and inhibition of diacylglycerol lipase activity

Meghan Johnston, Shachi R. Bhatt, Surina Sikka et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 22 citations · Full text

, , +9

Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody–Drug Conjugates (ADCs)

Emily E. Reid, Katie E. Archer, Manami Shizuka et al. · ACS Medicinal Chemistry Letters · 2019 · 20 citations · Full text

, , +17

Abstract 2890: IMGN151 - A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression

Olga Ab, Laura M. Bartle, Leanne Lanieri et al. · Cancer Research · 2020 · 14 citations

, , +17

1–5 of 5